Fairfield, Bush & Co’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40	Closed	-$4.58K	–	448
2023 Q2	$4.58K	Buy	+40	New	+$4.58K	﹤0.01%	376
2022 Q3	–	Sell	-40	Closed	-$3K	–	413
2022 Q2	$3K	Buy	+40	New	+$3K	﹤0.01%	382